Serum NLRC4 and MCP2/CCL8 levels are involved in the pathogenesis of CD and may have a protective effect on intestinal homeostasis and inflammation and could be used as a diagnostic tool and therapeutic target for CD. This evidence concerns the gene CCL8 and Cowden disease.